Melanotan II Research Guide (Preclinical Overview)
Melanotan II (MT-II) is a synthetic, cyclic lactam analog of alpha-melanocyte-stimulating hormone (α-MSH) widely investigated in preclinical settings for its non-selective agonism across melanocortin receptor subtypes. This technical guide outlines the molecular architecture, receptor binding profiles, melanogenesis research pathways, and rigorous analytical quality parameters required for conducting reproducible in vitro and ex vivo laboratory research.
Quick answer
Melanotan II (MT-II) is a synthetic, cyclic lactam analog of alpha-melanocyte-stimulating hormone (α-MSH) widely investigated in preclinical settings for its non-selective agonism across melanocortin receptor subtypes. This technical guide outlines the molecular architecture, receptor binding profiles, melanogenesis research pathways, and rigorous analytical quality parameters required for conducting reproducible in vitro and ex vivo laboratory research.
Key takeaways
- [Melanotan](/research-peptides/melanotan-2) II (MT-II) represents a structural derivative of naturally occurring endogenous α-MSH, designed specifically to evaluate melanocortin signaling pathways in controlled laboratory models.
- Chemically designated as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, [Melanotan](/research-peptides/melanotan-2) II is a cyclic heptapeptide analog.
- The melanocortin system comprises five distinct G-protein-coupled receptors (GPCRs), designated MC1R through MC5R.
- In cell culture models utilizing primary mammalian melanocytes or B16-F10 melanoma cell lines, exposure to [Melanotan](/research-peptides/melanotan-2) II induces a measurable, concentration-dependent increase in tyrosinase activity and eumelanin synthesis.
Introduction to Melanotan II in Preclinical Research
Melanotan II (MT-II) represents a structural derivative of naturally occurring endogenous α-MSH, designed specifically to evaluate melanocortin signaling pathways in controlled laboratory models. Developed initially during investigations into peptide-mediated photoprotection and melanogenesis, MT-II incorporates a constrained cyclic structure that significantly enhances enzymatic stability compared to native linear peptides. Researchers utilize this compound to explore the functional cascade of melanocortin signaling, extracellular ligand-receptor interactions, and intracellular second-messenger pathways.
As a research compound, Melanotan II is restricted strictly to laboratory evaluation, including cell culture assays, membrane binding experiments, and animal tissue model systems. Understanding its basic chemical structure and broad receptor specificity enables principal investigators to design targeted experiments that isolate specific physiological, biochemical, or dermatological mechanisms in non-human subjects.
Chemical Structure, Conformation, and Enzymatic Stability
Chemically designated as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, Melanotan II is a cyclic heptapeptide analog. The strategic incorporation of a D-phenylalanine residue at position 7, alongside a lactam bridge formed between the side chains of aspartic acid and lysine, locks the molecule into a rigid, bio-active reverse-turn conformation. This structural modification fundamentally alters how the peptide interacts with enzymatic degradation pathways.
Endogenous linear peptides like α-MSH exhibit brief half-lives in biological matrices due to rapid cleavage by serum exopeptidases and endopeptidases. The cyclic lactam structure of Melanotan II confers elevated resistance to enzymatic proteolysis, allowing researchers to study long-duration signaling kinetics in vitro without the rapid loss of active compound typical of native linear sequence fragments. Detailed discussions on peptide stability under various storage conditions can be found in our peptide handling and storage technical guide.
Melanocortin Receptor Binding Specificity and Signaling Cascades
The melanocortin system comprises five distinct G-protein-coupled receptors (GPCRs), designated MC1R through MC5R. Melanotan II functions as a potent, non-selective full agonist across four of these five subtypes, showing high affinity for MC1R, MC3R, MC4R, and MC5R, while exhibiting negligible activity at MC2R (the adrenal ACTH receptor).
Binding of MT-II to its target GPCRs stimulates heterotrimeric Gs proteins, activating adenylyl cyclase and triggering a downstream increase in intracellular cyclic adenosine monophosphate (cAMP). Elevated cAMP levels activate protein kinase A (PKA), leading to the phosphorylation of the cAMP response element-binding protein (CREB). In melanocyte model systems, CREB activation transcriptionally upregulates Microphthalmia-associated Transcription Factor (MITF), the master transcriptional regulator of key melanogenic enzymes including tyrosinase, tyrosinase-related protein 1 (TRP-1), and tyrosinase-related protein 2 (TRP-2). Investigators exploring broader receptor networks can review our index on melanocortin receptor agonists within the PX1 research library hub.
In Vitro Melanogenesis and Pigmentation Models
In cell culture models utilizing primary mammalian melanocytes or B16-F10 melanoma cell lines, exposure to Melanotan II induces a measurable, concentration-dependent increase in tyrosinase activity and eumelanin synthesis. Eumelanin—the dark photoprotective pigment—is synthesized within specialized membrane-bound organelles termed melanosomes. Preclinical data indicate that MT-II activation of MC1R accelerates melanosome maturation and facilitates pigment transfer to neighboring keratinocytes in organotypic skin culture models.
Because MT-II bypassed the requirement for ultraviolet radiation to trigger melanogenesis in baseline in vitro assays, researchers utilize it to isolate the receptor-driven enzymatic pathways of pigment formation from UV-induced DNA damage pathways. This distinction makes MT-II a vital tool in investigating dark-pigment synthesis, oxidative stress attenuation in cutaneous cells, and melanocyte proliferation control.
Comparative Analysis: Melanotan II, Melanotan I, and Bremelanotide
When designing melanocortin system studies, selecting the appropriate reference compound is critical to experimental control. Melanotan I (Afamelanotide) is a linear peptide analog ([Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2]) that exhibits high selectivity for MC1R, making it ideal for studies strictly focused on photoprotection and cutaneous pigmentation without significant central nervous system receptor crosstalk.
In contrast, Melanotan II possesses a cyclic structure that facilitates blood-brain barrier permeability in animal models, resulting in concurrent activation of central MC3R and MC4R pathways. Meanwhile, Bremelanotide (PT-141), a metabolite derivative of MT-II possessing a hydroxylated C-terminus structure, is typically selected for studies specifically probing central nervous system pathways governing behavioral signaling. Researchers requiring high-volume supplies for comparative multi-well assays can establish institutional purchasing protocols through our wholesale lab account portal.
Preclinical Laboratory Models and Research Frameworks
In preclinical animal models—primarily rodents—Melanotan II has been evaluated across diverse physiological dimensions beyond melanogenesis. Due to its potent central MC4R agonism, MT-II is frequently deployed in neuroendocrine research to analyze metabolic rate regulation, energy homeostasis, and food intake suppression in Murine models of obesity.
In vitro receptor binding assays routinely evaluate MT-II utilizing radiolabeled ligand displacement (e.g., [125I]-labeled α-MSH) or fluorometric cAMP accumulation assays to determine EC50 values across cloned human melanocortin receptors. These standardized experimental frameworks provide high-precision quantitative data regarding receptor occupancy, desensitization kinetics, and receptor internalization parameters.
Analytical Purity, Synthesis, and Quality Control Parameters
The reliability of preclinical data depends entirely on the chemical purity and analytical consistency of the research peptides used. Melanotan II is produced via automated Solid-Phase Peptide Synthesis (SPPS) using Fmoc chemistry protocols. Post-synthesis purification is conducted using Preparative Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to remove truncated sequences, residual reagents, and diastereomeric impurities.
PX1 Research ensures that every production lot undergoes rigorous analytical characterization. Identity is confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise molecular weight (1024.2 g/mol), while analytical RP-HPLC quantifies chemical purity, ensuring every lot meets or exceeds our strict ≥98% purity standard. Furthermore, all batches undergo third-party testing in an ISO 17025 accredited laboratory to verify low bacterial endotoxin levels (evaluated via Limulus Amebocyte Lysate assay) and to confirm the complete absence of residual heavy metals or synthetic solvents.
Laboratory Reconstitution and Handling Protocol
Melanotan II is supplied as a lyophilized (freeze-dried) powder sealed under inert gas to prevent oxidative degradation. To prepare the compound for in vitro or ex vivo experimental applications, proper laboratory reconstitution procedures must be followed strictly under aseptic conditions using a laminar flow hood.
To reconstitute, researchers typically add sterile Bacteriostatic Water or phosphate-buffered saline (PBS) gently down the glass wall of the vial to avoid agitating the peptide matrix. Swirl gently until completely dissolved; vortexing should be avoided as mechanical shear stress can disrupt secondary peptide conformations. Solubilized stock solutions should be aliquoted into single-use polypropylene microtubes to avoid repeated freeze-thaw cycles and stored at -20°C or -80°C. Complete quantitative calculations for lab preparations can be modeled using our peptide reconstitution calculator.
PX1 Research Sourcing and Supply Chain Guarantees
PX1 Research serves as a trusted primary supplier of ultra-pure research chemicals for academic institutions, biotechnology organizations, and analytical laboratories across the United States. Synthesized in state-of-the-art, GMP-compliant facilities within the USA, our compounds adhere to the highest industry standards for purity, stability, and batch-to-batch consistency.
Every shipment from PX1 Research includes a comprehensive, lot-specific Certificate of Analysis (COA) detailing HPLC chromatograms and mass spectra verification. To prevent experimental delays in fast-paced research environments, PX1 ships directly from specialized distribution centers in California and Arizona, offering same-day dispatch for orders placed Monday through Friday before 3:00 PM EST.
Frequently Asked Questions
What is the primary mechanism of action for Melanotan II in preclinical models?
Melanotan II acts as a potent, non-selective agonist of melanocortin receptors (MC1R, MC3R, MC4R, and MC5R). Upon binding, it stimulates adenylyl cyclase activity, elevating intracellular cAMP levels and triggering downstream signaling cascades such as PKA and CREB activation.
How does Melanotan II differ structurally from native alpha-MSH?
Unlike native linear alpha-MSH, Melanotan II is a synthetically constrained cyclic lactam heptapeptide featuring a D-phenylalanine substitution at position 7. This cyclic structure confers significantly higher enzymatic stability and prolonged receptor binding activity compared to linear peptides.
What purity levels are guaranteed for PX1 Research Melanotan II?
PX1 Research supplies Melanotan II verified at ≥98% purity via analytical RP-HPLC. Every lot undergoes independent verification at an ISO 17025 accredited laboratory, with Mass Spectrometry analysis confirming correct molecular mass.
How is endotoxin testing performed on PX1 research peptides?
Endotoxin levels are quantified using standardized Limulus Amebocyte Lysate (LAL) chromogenic assays. PX1 sets strict endotoxin thresholds to ensure compounds are suitable for sensitive cell culture and in vitro biochemical research.
How should lyophilized Melanotan II be stored upon receipt in the laboratory?
Lyophilized Melanotan II powder should be stored at -20°C in a desiccated environment protected from light. Under these conditions, the peptide remains stable for up to 24 months. Reconstituted liquid stock aliquots should be stored at -80°C to prevent degradation.
What is the primary functional difference between Melanotan I and Melanotan II in assays?
Melanotan I (Afamelanotide) is a linear peptide selective primarily for MC1R, making it ideal for isolated pigmentation studies. Melanotan II is a cyclic analog with broad affinity across MC1R, MC3R, MC4R, and MC5R, making it suitable for broader neuroendocrine and receptor cross-talk investigations.
Can Melanotan II be used in human subjects or clinical settings?
No. Melanotan II supplied by PX1 Research is strictly designated for laboratory research use only by qualified investigators. It is not for human or animal consumption, diagnostic use, or therapeutic applications.
What diluents are recommended for reconstituting MT-II for cell culture assays?
Reconstitution is typically performed using sterile laboratory-grade Bacteriostatic Water, microfiltered Deionized Water, or sterile Phosphate-Buffered Saline (PBS pH 7.4), depending on the specific buffer requirements of the target assay.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.